[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "Locally Advanced NSCLC",
            "Non-small Cell Lung Cancer",
            "Cancer",
            "Lung",
            "Unresectable",
            "Stage III"
        ],
        "dcp_id": null,
        "interventional_model": "Factorial",
        "lead_org": "MedImmune Inc",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Written informed consent and any locally required authorization obtained from the subject prior to performing any protocol-related procedures, including screening evaluation"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Age 18 years or older"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Body weight \u2265 35 kg"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Subjects must have histologically or cytologically documented NSCLC who present with locally advanced, unresectable, Stage III disease"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Subjects must have completed, without progressing, definitive cCRT within 42 days prior to being randomized into the study:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Provision of tumor tissue sample, when available, from original diagnosis obtained before initiation of chemoradiotherapy"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Life expectancy \u2265 12 weeks"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Subjects must have at least one previously irradiated tumor lesion that can be measured by RECIST v1.1"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 9,
                    "description": "Mixed small cell and non-small cell lung cancer histology"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 10,
                    "description": "Current or prior use of immunosuppressive medication within 14 days before the first dose of study drug."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 11,
                    "description": "Prior exposure to any anti-PD1, anti-PD-L1, or anti-CTLA4 antibody for treatment of NSCLC"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 12,
                    "description": "Subjects with history of \u2265 Grade 2 pneumonitis from prior chemoradiation therapy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 13,
                    "description": "Subjects with a history of venous thrombosis within the past 3 months"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Subjects with history of myocardial infarction, transient ischemic attack, or stroke in the past 6 months"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Congestive heart failure"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Active or prior documented autoimmune or inflammatory disorders"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "History of active primary immunodeficiency"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Active infection including tuberculosis, hepatitis B, hepatitis C, or human immunodeficiency virus (HIV)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "History of allogenic organ transplantation"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "QTcF interval \u2265 470 ms"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "History of another primary malignancy"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "Concurrent enrollment in another therapeutic clinical study or during the follow-up period of an interventional study. Enrollment in observational studies will be allowed"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Females who are pregnant, lactating, or intend to become pregnant during their participation in the study"
                }
            ],
            "structured": {
                "max_age": "99 Years",
                "max_age_number": 99.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 99.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "Study D9108C00001 (COAST) is a Phase 2, open-label, multicenter, randomized multidrug\r\n      platform study assessing the efficacy and safety of durvalumab alone vs durvalumab in\r\n      combination with novel agents in subjects with locally advanced, unresectable, Stage III\r\n      non-small cell lung cancer (NSCLC).",
        "official_title": "A Phase 2 Open-label, Multicenter, Randomized, Multidrug Platform Study of Durvalumab (MEDI4736) Alone or in Combination With Novel Agents in Subjects With Locally Advanced, Unresectable (Stage III) Non-small Cell Lung Cancer (COAST)",
        "_phase_sort_order": 2,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "From randomization up to 15 months after first treatment",
                "name": "Development of detectable anti-drug antibody (ADA) to durvalumab",
                "description": "Immunogenicity of durvalumab",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From randomization up to 15 months after first treatment",
                "name": "Development of detectable anti-drug antibody (ADA) to durvalumab or novel biologic agents",
                "description": "Immunogenicity of durvalumab alone and/or in combination with novel biologic agents",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of randomization until disease progression or up to a maximum of 5 years",
                "name": "Disease Control (DC) as a measure of efficacy of durvalumab alone vs durvalumab in combination with novel agents",
                "description": "confirmed CR, confirmed PR, or SD based on RECIST v1.1",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of first documented response until disease progression or up to a maximum of 5 years after randomization",
                "name": "Duration of Response (DoR) as a measure of efficacy of durvalumab alone vs durvalumab in combination with novel agents",
                "description": "The duration from the first documentation of a subsequently confirmed OR to the first documentation of a disease progression according to RECIST v1.1 or death due to any cause, whichever occurs first. Only subjects who have achieved OR (confirmed CR or confirmed PR) will be evaluated for DoR",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From time of informed consent through treatment period (12 months) or up to 3 months post last dose of study treatment",
                "name": "Incidence of Adverse Events as a measure of safety during the treatment period",
                "description": "The secondary endpoint of safety as assessed by the presence of adverse events and serious adverse events",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From screening until disease progression or death, up to a maximum of 5 years after randomization",
                "name": "Incidence of clinically significant vital sign values as a measure of safety",
                "description": "Assess the presence of clinically significant vital sign values from baseline",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From screening until disease progression or death, up to a maximum of 5 years after randomization",
                "name": "Number of patients with clinically significant laboratory values as a measure of safety",
                "description": "Assess the presence of clinically significant laboratory values taken at times indicated in the assessment schedule from baseline in terms of number of patients with abnormal values",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "ORR at 16weeks after randomization is the timing for radiologic assessment of the primary endpoint",
                "name": "Objective Response (OR) rate as a measure of antitumor activity of durvalumab alone vs durvalumab in combination with novel agents",
                "description": "Best overall response of confirmed CR or confirmed PR according to RECIST v1.1",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From time of randomization until disease progression or up to a maximum of 5 years",
                "name": "Progression-Free Survival (PFS) and Progression-Free Survival 12 month landmark rate (PFS-12) as a measure of efficacy of durvalumab alone vs durvalumab in combination with novel agents",
                "description": "From randomization until the first documentation of disease progression according to RECIST v1.1 or death due to any cause, whichever occurs first",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From randomization up to 15 months after first treatment",
                "name": "Serum concentration levels of durvalumab or novel agents",
                "description": "Pharmacokinetics of durvalumab alone and/or in combination with novel agents",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From randomization up to 15 months after first treatment",
                "name": "Serum durvalumab concentration levels",
                "description": "Pharmacokinetics of durvalumab",
                "type_code": "SECONDARY"
            }
        ],
        "phase": "II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT03822351",
        "biomarkers": [],
        "classification_code": null,
        "current_trial_status_date": "2020-07-31",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Stage III Lung Cancer AJCC v8",
                    "Stage III"
                ],
                "nci_thesaurus_concept_id": "C136478",
                "name": "Stage III Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136467"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA Lung Cancer AJCC v8",
                    "Stage IIIA"
                ],
                "nci_thesaurus_concept_id": "C136479",
                "name": "Stage IIIA Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136478"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB Lung Cancer AJCC v8",
                    "Stage IIIB"
                ],
                "nci_thesaurus_concept_id": "C136480",
                "name": "Stage IIIB Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136478"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIC Lung Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136481",
                "name": "Stage IIIC Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136478"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Non-Small Cell Lung Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C155901",
                "name": "Unresectable Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2926",
                    "C155902"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C160783",
                "name": "Locally Advanced Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156094",
                    "C153206"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Respiratory, Thoracic, and Mediastinal Disorder",
                    "Respiratory and Thoracic Disease",
                    "Respiratory, Thoracic, and Mediastinal Disease"
                ],
                "nci_thesaurus_concept_id": "C27669",
                "name": "Respiratory and Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Respiratory Tract Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4571",
                "name": "Malignant Respiratory System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3355",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Lung",
                    "Pulmonary Disorders",
                    "Pulmonary Disorder",
                    "Lung Disorders",
                    "Pulmonary Diseases",
                    "Pulmonary Disease"
                ],
                "nci_thesaurus_concept_id": "C3198",
                "name": "Lung Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26871",
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Neoplasm of the Lung",
                    "Malignant Tumor of Lung",
                    "Malignant Tumor of the Lung",
                    "Malignant Lung Tumor",
                    "Malignant Neoplasm of Lung"
                ],
                "nci_thesaurus_concept_id": "C7377",
                "name": "Malignant Lung Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C4571",
                    "C3200"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Respiratory Tract Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3355",
                "name": "Respiratory System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26871",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Lung cancer, NOS",
                    "Lung Carcinoma",
                    "Cancer of Lung",
                    "Carcinoma of the Lung",
                    "Cancer of the Lung",
                    "Lung Cancer (all types)",
                    "Carcinoma of Lung"
                ],
                "nci_thesaurus_concept_id": "C4878",
                "name": "Lung Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C7377"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor Stage (Pathological)"
                ],
                "nci_thesaurus_concept_id": "C136467",
                "name": "Lung Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4878"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disorder of Respiratory System",
                    "Respiratory Disorder",
                    "Unspecified Respiratory Problem"
                ],
                "nci_thesaurus_concept_id": "C26871",
                "name": "Respiratory System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Tumor of Thorax",
                    "Malignant Neoplasm of Thorax",
                    "Malignant Thoracic Tumor",
                    "Malignant Tumor of the Thorax",
                    "Malignant Neoplasm of the Thorax"
                ],
                "nci_thesaurus_concept_id": "C3576",
                "name": "Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3406"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Lung Tumor",
                    "Neoplasm of the Lung",
                    "Tumor of the Lung",
                    "Tumor of Lung",
                    "Neoplasm of Lung",
                    "Lung Neoplasms"
                ],
                "nci_thesaurus_concept_id": "C3200",
                "name": "Lung Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3355",
                    "C3198",
                    "C3406"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor of the Thorax",
                    "Neoplasm of Thorax",
                    "Thoracic Tumor",
                    "Neoplasm of the Thorax",
                    "Tumor of Thorax"
                ],
                "nci_thesaurus_concept_id": "C3406",
                "name": "Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Thoracic Disease"
                ],
                "nci_thesaurus_concept_id": "C35742",
                "name": "Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153202",
                "name": "Metastatic Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C176862",
                    "C4878",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C155902",
                "name": "Unresectable Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4878",
                    "C148124",
                    "C179420"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148124",
                "name": "Unresectable Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C27359"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C65151",
                "name": "Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C179420",
                "name": "Unresectable Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27359",
                    "C3576"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176862",
                "name": "Metastatic Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C3576"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153206",
                "name": "Locally Advanced Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C148130",
                    "C153202"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Unresectable Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C27359",
                "name": "Unresectable Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "regional cancer",
                    "Locally advanced",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165537",
                "name": "Metastatic Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C65151"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156094",
                "name": "Metastatic Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2926",
                    "C165537",
                    "C153202"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Non-Small Cell Carcinoma of Lung",
                    "Lung Non-Small Cell Carcinoma",
                    "Non-Small Cell Cancer of Lung",
                    "NSCLC - Non-Small Cell Lung Cancer",
                    "Non-Small Cell Carcinoma of the Lung",
                    "Non-Small Cell Lung Carcinoma",
                    "Non Small Cell Lung Cancer NOS",
                    "Non-Small Cell Cancer of the Lung",
                    "NSCLC",
                    "Non-small cell lung cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C2926",
                "name": "Non-Small Cell Lung Cancer",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C4878",
                    "C65151"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148130",
                "name": "Locally Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C3482"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "D9108C00001",
        "active_sites_count": 2,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [],
                "name": "Arm A (durvalumab + oleclumab):",
                "description": "durvalumab IV and oleclumab IV",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Arm B (durvalumab + monalizumab)",
                "description": "durvalumab IV and monalizumab IV",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biologicals",
                            "Biological Products",
                            "Biologics",
                            "Immunologic, Immunochemical",
                            "Biopharmaceuticals",
                            "Immunologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C141144",
                        "name": "Immune Checkpoint Modulator",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C143250",
                        "name": "Immune Checkpoint Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C141144"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Monoclonal Antibodies",
                            "Monoclonal Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C20401",
                        "name": "Monoclonal Antibody Therapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Therapeutic Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Anti-tumor Targeted Therapy Agent",
                            "Targeted Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological",
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Antibody",
                            "Antineoplastic Ab",
                            "Anticancer Antibody"
                        ],
                        "nci_thesaurus_concept_id": "C129822",
                        "name": "Antineoplastic Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C128057",
                        "name": "Anti-PD-L1 Monoclonal Antibody",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C191689",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Biological Response Modifier",
                            "Immunotherapy Agent",
                            "Immunomodulators",
                            "Immunotherapeutic Agent",
                            "Immunopotentiators",
                            "Immune Modulators",
                            "Immune Mediators",
                            "Immune Regulators",
                            "Biomodulators",
                            "Immunomodulating Agent",
                            "Immunomodulatory Agent",
                            "BRM"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C120208",
                        "name": "Monalizumab",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "PD-1 Ligand-targeting Agent",
                            "PD-1 Ligands Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C156893",
                        "name": "PD-1 Ligand Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C143250",
                            "C163758"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Drug Substance",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent",
                            "Drug",
                            "Agent",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Anti-Tumor Drugs",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Agents",
                            "Antiproliferative Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs",
                            "Cancer Drug",
                            "Antineoplastics"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [
                            "Imfinzi"
                        ],
                        "nci_thesaurus_concept_id": "C103194",
                        "name": "Durvalumab",
                        "description": "A monoclonal antibody directed against B7H1 (B7 homolog 1; programmed cell death ligand 1) with potential immunostimulating activity. Upon intravenous administration, MEDI4736 binds to the cell surface antigen B7H1, thereby blocking B7H1 signaling. This may activate the immune system to exert a cytotoxic T-lymphocyte (CTL) response against B7H1-expressing tumor cells. B7H1, a member of the B7 protein superfamily and a negative regulator of cytokine synthesis, is overexpressed on certain tumor cell types. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C128057"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C123914",
                        "name": "Oleclumab",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent",
                        "parents": [
                            "C129822",
                            "C20401"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-PD-L1 Agent",
                            "PD-L1-targeting Agent",
                            "Anti-CD274 Agent",
                            "CD274-targeting Agent"
                        ],
                        "nci_thesaurus_concept_id": "C191689",
                        "name": "PD-L1 Inhibitor",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": [
                            "C156893"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Biological/Vaccine",
                        "category": "agent category",
                        "parents": []
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Control Arm (Durvalumab monotherapy)",
                "description": "durvalumab IV",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2019-02118",
        "why_study_stopped": null,
        "brief_summary": "The purpose of this study is to compare the clinical activity of durvalumab alone vs\r\n      durvalumab in combination with novel agents. The overall study goal is early identification\r\n      of novel durvalumab combinations that are more active than durvalumab alone in the treatment\r\n      of patients with unresectable, Stage III NSCLC who have not progressed after cCRT.",
        "brief_title": "Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC",
        "status_history": [
            {
                "status_date": "2020-07-31T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2018-12-19T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 189,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2018-12-19",
        "record_verification_date": "2023-02-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Randomized Controlled Trial"
        },
        "acronym": "COAST",
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Lung"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-06-21",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]